Literature DB >> 20633039

Early cognitive development in children born to women with epilepsy: a prospective report.

Rebecca L Bromley1, George Mawer, Jenna Love, James Kelly, Laura Purdy, Lauren McEwan, Maria Briggs, Jill Clayton-Smith, Xin Shi, Xin Sin, Gus A Baker.   

Abstract

PURPOSE: In this prospective study the early cognitive development of children born to women with epilepsy (n = 198) was assessed and compared to a group of children representative of the general population (n = 230).
METHODS: The children were assessed when younger than the age of 2 years using the Griffiths Mental Development Scales, either in their local participating hospital or in their home. The assessments were completed by an assessor who was blinded to whether the child's mother had epilepsy and to antiepileptic drug type.
RESULTS: Children exposed to sodium valproate had a statistically significant increased risk of delayed early development in comparison to the control children. Linear regression analysis showed a statistically significant effect of sodium valproate exposure on the child's overall developmental level that was not accounted for by confounding variables. Delayed early development is also noted for children within an ad hoc group of less commonly utilized antiepileptic drugs, although conclusions cannot be drawn due to the size of this group (n = 13). Children exposed to either carbamazepine or lamotrigine in utero did not differ significantly in their overall developmental ability. Differences noted in specific developmental areas for these two groups were not statistically significant after the control for confounders such as socioeconomic status and maternal IQ. DISCUSSION: Women with epilepsy should be informed of the risks posed to their potential offspring prior to pregnancy to allow for informed decisions regarding treatment. Children exposed in utero to antiepileptic drugs should be monitored throughout childhood to allow for early intervention when necessary. Wiley Periodicals, Inc.
© 2010 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633039     DOI: 10.1111/j.1528-1167.2010.02668.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  34 in total

1.  Early discontinuation of antiseizure medications in neonates with hypoxic-ischemic encephalopathy.

Authors:  Mark P Fitzgerald; Sudha Kilaru Kessler; Nicholas S Abend
Journal:  Epilepsia       Date:  2017-04-12       Impact factor: 5.864

2.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 3.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 4.  Neurodevelopmental Effects of Antiepileptic Drugs.

Authors:  Marissa Kellogg; Kimford J Meador
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

5.  Comments on Motamedi G, Meador K. Epilepsy and cognition. Epilepsy & behavior 2003;4:S25-S28.

Authors:  Robyn M Busch
Journal:  Epilepsy Behav       Date:  2014-10-11       Impact factor: 2.937

Review 6.  Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?

Authors:  David S Baldwin; Hugo J F Amaro
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 7.  [Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

Review 8.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

Review 9.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

10.  The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.

Authors:  Rebecca Louise Bromley; George E Mawer; Maria Briggs; Christopher Cheyne; Jill Clayton-Smith; Marta García-Fiñana; Rachel Kneen; Sam B Lucas; Rebekah Shallcross; Gus A Baker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-31       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.